ILTS Insights – Synopsis of the Guideline Statements on DCD Liver Transplantation of the 2020 ILTS Consensus Conference
On April 22, Andrea Schlegel, Amelia Hessheimer and Kristopher Croome will present the statements and recommendations of the ILTS Consensus Conference on DCD liver transplantation in 2020.
ILTS Insights: Synopsis of the Guideline Statements on DCD Liver Transplantation of the 2020 ILTS Consensus Conference
Date: April 22, 2021
Time: 3:00 PM CET / 9:00 AM EST
In this webinar, the statements and recommendations of the ILTS Consensus Conference on DCD liver transplantation in 2020 will be presented by three experts in the field: Andrea Schlegel, Amelia Hessheimer & Kristopher Croome.
Summarize the highlights of the Consensus Conference on DCD liver transplantation.
- Donor warm ischemia time
- Donor & recipient selection
- Complication management
- Organ procurement, including NRP
- Introduction by Marit Kalisvaart
- Donor and recipient selection and complications in DCD (Andrea Schlegel)
- Regulations and procurement Surgery in DCD, including the use of normothermic regional perfusion (Amelia Hessheimer)
- How to improve outcomes of DCD liver transplantation? (Kristopher Croome)
- Q&A moderated by Wojciech Polak & Marit Kalisvaart
|Andrea Schlegel is a certified transplant and HPB surgeon, currently working at the Careggi University Hospital in Florence, Italy. In addition to protective mechanisms of novel machine perfusion technology, her research focuses on risk assessment in liver transplantation and the use of extended criteria donor livers, including DCD.|
|Amelia Hessheimer is a Specialist in Hepatopancreatobiliary Surgery & Liver Transplantation Unit at the Hospital Clínic in Barcelona, Spain. Dr Hessheimer has a background in Chemistry, Medicine, and Surgery. Currently, Dr Hessheimer performs both clinical and experimental work in the field of liver transplantation, with primary areas of focus related to donation after circulatory death, perfusion technologies, and strategies for the successful transplantation of partial liver grafts.|
|Kristopher Croome is an Associate Professor of Surgery at Mayo Clinic Florida. He completed his surgical residency at the University of Western Ontario in Canada. He took time during his residency and completed a graduate degree in epidemiology and statistics from Harvard University as well as a research fellowship through Beth-Israel Deaconess Medical center in Boston. He subsequently completed an abdominal transplant fellowship at the University of Western Ontario, followed by a fellowship in hepatobiliary surgery from Mayo Clinic in Rochester. Dr Croome is currently an Associate Editor for the Journal: Liver Transplantation. His research interests include donation after circulatory death liver transplantation, donor liver steatosis, ischemia–reperfusion injury, and liver regeneration. He has over 100 peer-reviewed publications in transplant and HPB surgery.|
|Wojciech Polak, MD, PhD, was trained as a surgeon in Poland. During his fellowship at the UMCG in Groningen, he specialized further in transplant surgery (organ removal, liver and kidney transplants) and in the surgery of liver, pancreas, and bile ducts. Since 2009, Dr Polak is working as a surgeon in Erasmus MC, Rotterdam, with a focus on liver and bile duct surgery and transplant surgery. He is the surgical program leader of liver transplants at Erasmus MC since 2016. Dr Polak is also a current Chair of the European Liver and Intestine Transplant Association.|
|Marit Kalisvaart, MD, PhD, is a surgical trainee from the Netherlands. Currently, she works as a general surgery resident and researcher in HPB surgery and liver transplantation at the Department of Surgery and Organ Transplantation at the University Hospital in Zurich, Switzerland. Marit Kalisvaart is a member of the ILTS Vanguard Committee and topic coordinator of the ILTS DCD & Machine Perfusion Special Interest Group.|
This Webinar is Supported by Bridge to Life
ILTS would like to thank Bridge to Life for their generous support for the production of this webinar. Bridge to Life has had no influence on the content, and full editorial control remains the sole responsibility of ILTS.
|Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, Bridge to Life continues to explore emerging science and preservation technologies.|